Keywords: USA, Biologics Price Competition Act, BPCIA, HP&M, Product exclusivity

Another week, another missive on US BPCIA exclusivity

Article | 31 January 2011

In yet another letter to US Food and Drug Administration Commissioner Margaret Hamburg concerning the 12-year period of reference product ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in